CLEVELAND, Ohio — Case Western Reserve University is hoping to offer the first therapy for an inherited eye disease leading to blindness. Shigemi Matsuyama, an associate professor of ophthalmology and ...
There’s only one U.S. Food and Drug Administration-approved therapy for an inherited retinal disease, and dozens of retinitis pigmentosa (RP) genes for which no therapy is available. With a new ...
The term “goldeneye” once only described spy thrillers and waterfowl. But soon, it could mean groundbreaking therapy for people with failing vision. At first glance, the method may seem ...
Paris, October 21, 2020 – SparingVision (“the Company”), a genomic medicine company focused on ocular diseases, today announces a €44.5 million financing round. The round was led by 4BIO Capital ...
BERKELEY, Calif., April 29, 2026--(BUSINESS WIRE)--Ray Therapeutics (RayTx), an industry-leading clinical-stage biopharmaceutical company pioneering differentiated vision restoration therapies for ...
MALVERN, Pa., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell ...
Add Yahoo as a preferred source to see more of our stories on Google. A new study suggests that injecting gold nanoparticles into the retina and stimulating those particles with lasers could restore ...
The term “goldeneye” once only described spy thrillers and waterfowl. But soon, it could mean groundbreaking therapy for people with failing vision. At first glance, the method may seem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results